- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03495947
High Flow Nasal Cannula in Immediately Post Extubation (HFNC)
Evaluation of Results of the Application of High Flow Nasal Cannula to Prevent the Failure of Extubation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At the end of the successful spontaneous breathing trial, clinical and gasometric parameters will be recorded and extubation will be performed. HFNC is placed with a flow of 50 l / m (only the flow is reduced before intolerance, at 5 l / min but only up to 40 l / min). Inspiratory oxygen fraction (FiO2) initially at 1 and progressively decreases until pulse oximeter saturation (SpO2) ≥ 92% is achieved. Said configuration is maintained for 60 minutes. After this time, arterial blood samples are taken and clinical and gasometric parameters are recorded in the follow-up chart. Based on them, behavior to be followed is defined. If "Fault criteria" are presented, a higher ventilatory support will be initiated. If not, continue with HFNC for the next 23 hours without exception. In this period the initial flow is maintained (40 to 50 l / min) and the FiO2 is programmed according to the SpO2 objective (≥ 92%). At 6 o'clock a new clinical and gasometric evaluation and data loading is carried out. 24 hours after the start of HFNC, a blood gas sample is taken and clinical and gasometric parameters are recorded. Treatment with HFNC is only suspended if the "Failure criteria" or the "Interruption criteria" are met. In the presence of the "Failure Criteria" and prior to delivering a greater ventilatory support, the clinical and gasometric parameters are recorded in the spreadsheet.
The data of categorical variables will be presented as frequency and percentage, while in quantitative variables, after testing normality by Shapiro-Wilks test, they will be presented as mean and standard deviation or median and interquartile range depending on their distribution. For comparisons between groups, chi-square or Fisher tests will be used, depending on the frequency expected in discrete and categorical variables, and in the continuous T or Mann-Whitney tests, depending on the type of distribution and variance. To determine the factors of risk of failure to extubation, a logistic regression study will be carried out with a system of selection of variables by forward steps. The odds ratio and its 95% confidence intervals will be calculated. Variables that are significant in the univariate study (p value <0.2) will be included in the multiple logistic regression study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Buenos Aires, Argentina, C1181ACH
- Hospital Italiano de Buenos Aires
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- All adult patients receiving invasive mechanical ventilation ≥48 hours and ready for scheduled extubation according to tolerance of spontaneous breathing trial, with at least one of the following criteria for high-risk for extubation failure:
- Age greater than 65 years.
- Hypoxemic acute respiratory failure as a cause of invasive mechanical ventilation.
- >1 spontaneous ventilation test failed consecutive.
- History of chronic heart failure.
- History of chronic obstructive pulmonary disease or PaCO2 >45 mmHg.
- Body mass index >30 kg/m2.
- Post-operative solid organ transplantation.
Exclusion criteria:
- Need for orotracheal intubation and invasive mechanical ventilation (IOT / AVMI) according to the decision of the attending physician.
- Deterioration of the state of consciousness determined by Kelly Matthay's Scale >3.
- Hemodynamic instability: systolic blood pressure (TAS) <90 mmHg or TAM <65 mmHg despite receiving fluids and/ or vasopressors.
- Neuromuscular disease
- Neurocritical pathology.
- Epistaxis
- Skull base fracture, or inability to fix the HFNC.
- History of obstructive sleep apnea-hypopnea syndrome with indication and use of nocturnal continuous positive pressure.
- Participation in another research protocol of HFNC.
Elimination criteria
. Directives before or after the onset of a disease that limits the therapeutic effort and indicates not to intubate or perform cardiopulmonary resuscitation.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Extubation failure
Time Frame: In the first 48 hours
|
the need to discontinue treatment with HFNC to progress to invasive or non-invasive ventilatory support within 48 hours of extubation.
|
In the first 48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to failure of extubation
Time Frame: In the first 48 hours
|
the date and time of extubation and start of HFNC will be recorded as well as the date and time of discontinuation of HFNC to progress to another type of ventilatory support within 48 hours following extubation.
|
In the first 48 hours
|
Reasons for extubation failure
Time Frame: In the first 48 hours
|
the cause of extubation failure
|
In the first 48 hours
|
Type of ventilatory support post-failure of extubation
Time Frame: In the first 48 hours
|
the type of ventilatory support post-failure will be recorded.
Non-invasive mechanical ventilatory.
Intubation orotracheal and invasive mechanical ventilatory.
|
In the first 48 hours
|
Average time of use the HFNC
Time Frame: Through study completion, an average of 1 year
|
the total hours of use of HFNC will be recorded
|
Through study completion, an average of 1 year
|
Length of stay in the Intensive care unit
Time Frame: Through study completion, an average of 1 year
|
the total number of days of stay in the Intensive care unit will be recorded.
|
Through study completion, an average of 1 year
|
Incidence of mortality in the Intensive care unit
Time Frame: Through study completion, an average of 1 year
|
the relationship between the total number of patients requiring HFNC and those who died after being included in the study will be recorded.
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Paulina E Ezcurra, Lic
- Principal Investigator: Maria S Venuti, Dr
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3027
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Extubation
-
Hospital Universitario Doctor PesetRecruiting
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
Ottawa Hospital Research InstituteNot yet recruitingAirway ExtubationCanada
-
Ottawa Hospital Research InstituteRecruiting
-
Regional Hospital West JutlandUnknownAirway Extubation | Laparotomy | Anesthesia, Intravenous
-
Hamad Medical CorporationRecruitingHigh-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care PatientsAirway Extubation | Critical Care | Intensive Care | Oxygen TherapyQatar
-
Centro Hospitalar Unimed de JoinvilleRecruitingAirway Extubation | Ventilator WeaningBrazil
-
Severance HospitalCompletedAirway ExtubationKorea, Republic of
-
Lili JiaShanxi Province Cancer Hospital; The First Affiliated Hospital of Shanxi Medical... and other collaboratorsRecruiting
Clinical Trials on high flow nasal cannula
-
Aga Khan University Hospital, PakistanUnknownApneic Oxygenation
-
Hospital Clinic of BarcelonaUnknownPatient Population Submitted to ERCPSpain
-
Kuopio University HospitalCentral Finland Hospital District; Mikkeli Central Hospital; Siun soteRecruiting
-
Montefiore Medical CenterCompletedMorbid Obesity | Noninvasive Ventilation | Deep SedationUnited States
-
Samsung Medical CenterFisher and Paykel HealthcareNot yet recruitingAcute Respiratory FailureKorea, Republic of
-
Children's Hospital Los AngelesCompletedHigh Flow Nasal CannulaUnited States
-
American University of Beirut Medical CenterRecruitingHigh-flow Nasal Cannula | Intravenous SedationLebanon
-
Mount Sinai Hospital, CanadaPrincess Margaret Hospital, CanadaActive, not recruitingHypoxia | Hematologic Malignancy | Immunocompromised | Post Hematopoietic Stem Cell Transplant | Pulmonary InfiltratesCanada
-
Rush University Medical CenterHospital Civil de GuadalajaraRecruitingObesity, Morbid | Extubation FailureUnited States, Mexico